Nighttime sleep problems and daytime sleepiness in Parkinson's disease
Identifieur interne : 002733 ( Main/Exploration ); précédent : 002732; suivant : 002734Nighttime sleep problems and daytime sleepiness in Parkinson's disease
Auteurs : Dagmar Verbaan [Pays-Bas] ; Stephanie M. Van Rooden [Pays-Bas] ; Martine Visser [Pays-Bas] ; Johan Marinus [Pays-Bas] ; Jacobus J. Van Hilten [Pays-Bas]Source :
- Movement Disorders [ 0885-3185 ] ; 2008-01.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
- Adult, Antiparkinson Agents (therapeutic use), Demography, Depressive Disorder (epidemiology), Depressive Disorder (etiology), Depressive Disorder (psychology), Disorders of Excessive Somnolence (diagnosis), Disorders of Excessive Somnolence (epidemiology), Dyskinesias (diagnosis), Dyskinesias (epidemiology), Female, Humans, Insomnia, Levodopa (therapeutic use), Male, Middle Aged, Nervous system diseases, Parkinson Disease (drug therapy), Parkinson Disease (epidemiology), Parkinson Disease (psychology), Parkinson disease, Parkinson's disease, Polysomnography, Questionnaires, Risk Factors, SCOPA‐SLEEP, Severity of Illness Index, Sleep, Sleep Initiation and Maintenance Disorders (diagnosis), Sleep Initiation and Maintenance Disorders (epidemiology), Sleep disorder, excessive daytime sleepiness, insomnia, sleep.
- MESH :
- chemical , therapeutic use : Antiparkinson Agents, Levodopa.
- diagnosis : Disorders of Excessive Somnolence, Dyskinesias, Sleep Initiation and Maintenance Disorders.
- drug therapy : Parkinson Disease.
- epidemiology : Depressive Disorder, Disorders of Excessive Somnolence, Dyskinesias, Parkinson Disease, Sleep Initiation and Maintenance Disorders.
- etiology : Depressive Disorder.
- psychology : Depressive Disorder, Parkinson Disease.
- Adult, Demography, Female, Humans, Male, Middle Aged, Polysomnography, Questionnaires, Risk Factors, Severity of Illness Index.
Abstract
Our objective is to evaluate nighttime sleep problems (NSP) and daytime sleepiness (DS) in patients with Parkinson's disease (PD) compared to controls, and to assess relations with demographic, disease‐related, and clinical characteristics in patients. NSP and DS were evaluated with the SCOPA‐SLEEP questionnaire in PD patients and controls. In patients, other disease‐related and clinical characteristics were also evaluated. Four hundred twenty PD patients [mean (SD) age 61.1 (11.5) years] and 150 controls [mean (SD) age 60.9 (9.9) years] participated in the study. Compared to controls, a significantly greater proportion of patients had excessive DS (EDS) (43 vs. 10%), excessive NSP (ENSP) (27 vs. 9%), or used sleep medication (17 vs. 12%). Difficulties with falling asleep were similar in both groups. In both patients and controls, women experienced more NSP than men. In patients, depressive symptoms accounted for 21% of NSP variance and was the major contributor to the total explained variance (30%). Furthermore, NSP were related to dopamine‐agonist and levodopa dose, whereas DS was related to age, dopamine‐agonist dose, and disease severity. NSP and DS occur frequently in PD, with EDS being reported more commonly than ENSP. No strong relations were found between DS and demographic or clinical variables. The strong relation between NSP and depressive symptoms in PD calls for future studies to explore the nature of this relation. © 2007 Movement Disorder Society
Url:
DOI: 10.1002/mds.21727
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000B24
- to stream Istex, to step Curation: 000B24
- to stream Istex, to step Checkpoint: 001289
- to stream PubMed, to step Corpus: 002491
- to stream PubMed, to step Curation: 002491
- to stream PubMed, to step Checkpoint: 002184
- to stream Ncbi, to step Merge: 001E68
- to stream Ncbi, to step Curation: 001E68
- to stream Ncbi, to step Checkpoint: 001E68
- to stream Main, to step Merge: 003311
- to stream PascalFrancis, to step Corpus: 001420
- to stream PascalFrancis, to step Curation: 001899
- to stream PascalFrancis, to step Checkpoint: 001166
- to stream Main, to step Merge: 003774
- to stream Main, to step Curation: 002733
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Nighttime sleep problems and daytime sleepiness in Parkinson's disease</title>
<author><name sortKey="Verbaan, Dagmar" sort="Verbaan, Dagmar" uniqKey="Verbaan D" first="Dagmar" last="Verbaan">Dagmar Verbaan</name>
</author>
<author><name sortKey="Van Rooden, Stephanie M" sort="Van Rooden, Stephanie M" uniqKey="Van Rooden S" first="Stephanie M." last="Van Rooden">Stephanie M. Van Rooden</name>
</author>
<author><name sortKey="Visser, Martine" sort="Visser, Martine" uniqKey="Visser M" first="Martine" last="Visser">Martine Visser</name>
</author>
<author><name sortKey="Marinus, Johan" sort="Marinus, Johan" uniqKey="Marinus J" first="Johan" last="Marinus">Johan Marinus</name>
</author>
<author><name sortKey="Van Hilten, Jacobus J" sort="Van Hilten, Jacobus J" uniqKey="Van Hilten J" first="Jacobus J." last="Van Hilten">Jacobus J. Van Hilten</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:BEE00B7711D7D7DF1865090033D443D02661DFA4</idno>
<date when="2008" year="2008">2008</date>
<idno type="doi">10.1002/mds.21727</idno>
<idno type="url">https://api.istex.fr/document/BEE00B7711D7D7DF1865090033D443D02661DFA4/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000B24</idno>
<idno type="wicri:Area/Istex/Curation">000B24</idno>
<idno type="wicri:Area/Istex/Checkpoint">001289</idno>
<idno type="wicri:doubleKey">0885-3185:2008:Verbaan D:nighttime:sleep:problems</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:17960797</idno>
<idno type="wicri:Area/PubMed/Corpus">002491</idno>
<idno type="wicri:Area/PubMed/Curation">002491</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002184</idno>
<idno type="wicri:Area/Ncbi/Merge">001E68</idno>
<idno type="wicri:Area/Ncbi/Curation">001E68</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001E68</idno>
<idno type="wicri:Area/Main/Merge">003311</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:08-0115893</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001420</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001899</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">001166</idno>
<idno type="wicri:doubleKey">0885-3185:2008:Verbaan D:nighttime:sleep:problems</idno>
<idno type="wicri:Area/Main/Merge">003774</idno>
<idno type="wicri:Area/Main/Curation">002733</idno>
<idno type="wicri:Area/Main/Exploration">002733</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Nighttime sleep problems and daytime sleepiness in Parkinson's disease</title>
<author><name sortKey="Verbaan, Dagmar" sort="Verbaan, Dagmar" uniqKey="Verbaan D" first="Dagmar" last="Verbaan">Dagmar Verbaan</name>
<affiliation wicri:level="3"><country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Department of Neurology, Leiden University Medical Center, Leiden</wicri:regionArea>
<placeName><settlement type="city">Leyde</settlement>
<region nuts="2" type="province">Hollande-Méridionale</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Van Rooden, Stephanie M" sort="Van Rooden, Stephanie M" uniqKey="Van Rooden S" first="Stephanie M." last="Van Rooden">Stephanie M. Van Rooden</name>
<affiliation wicri:level="3"><country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Department of Neurology, Leiden University Medical Center, Leiden</wicri:regionArea>
<placeName><settlement type="city">Leyde</settlement>
<region nuts="2" type="province">Hollande-Méridionale</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Visser, Martine" sort="Visser, Martine" uniqKey="Visser M" first="Martine" last="Visser">Martine Visser</name>
<affiliation wicri:level="3"><country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Department of Neurology, Leiden University Medical Center, Leiden</wicri:regionArea>
<placeName><settlement type="city">Leyde</settlement>
<region nuts="2" type="province">Hollande-Méridionale</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Marinus, Johan" sort="Marinus, Johan" uniqKey="Marinus J" first="Johan" last="Marinus">Johan Marinus</name>
<affiliation wicri:level="3"><country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Department of Neurology, Leiden University Medical Center, Leiden</wicri:regionArea>
<placeName><settlement type="city">Leyde</settlement>
<region nuts="2" type="province">Hollande-Méridionale</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Van Hilten, Jacobus J" sort="Van Hilten, Jacobus J" uniqKey="Van Hilten J" first="Jacobus J." last="Van Hilten">Jacobus J. Van Hilten</name>
<affiliation wicri:level="3"><country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Department of Neurology, Leiden University Medical Center, Leiden</wicri:regionArea>
<placeName><settlement type="city">Leyde</settlement>
<region nuts="2" type="province">Hollande-Méridionale</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2008-01">2008-01</date>
<biblScope unit="vol">23</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="35">35</biblScope>
<biblScope unit="page" to="41">41</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">BEE00B7711D7D7DF1865090033D443D02661DFA4</idno>
<idno type="DOI">10.1002/mds.21727</idno>
<idno type="ArticleID">MDS21727</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Antiparkinson Agents (therapeutic use)</term>
<term>Demography</term>
<term>Depressive Disorder (epidemiology)</term>
<term>Depressive Disorder (etiology)</term>
<term>Depressive Disorder (psychology)</term>
<term>Disorders of Excessive Somnolence (diagnosis)</term>
<term>Disorders of Excessive Somnolence (epidemiology)</term>
<term>Dyskinesias (diagnosis)</term>
<term>Dyskinesias (epidemiology)</term>
<term>Female</term>
<term>Humans</term>
<term>Insomnia</term>
<term>Levodopa (therapeutic use)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Nervous system diseases</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Parkinson Disease (epidemiology)</term>
<term>Parkinson Disease (psychology)</term>
<term>Parkinson disease</term>
<term>Parkinson's disease</term>
<term>Polysomnography</term>
<term>Questionnaires</term>
<term>Risk Factors</term>
<term>SCOPA‐SLEEP</term>
<term>Severity of Illness Index</term>
<term>Sleep</term>
<term>Sleep Initiation and Maintenance Disorders (diagnosis)</term>
<term>Sleep Initiation and Maintenance Disorders (epidemiology)</term>
<term>Sleep disorder</term>
<term>excessive daytime sleepiness</term>
<term>insomnia</term>
<term>sleep</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Disorders of Excessive Somnolence</term>
<term>Dyskinesias</term>
<term>Sleep Initiation and Maintenance Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Depressive Disorder</term>
<term>Disorders of Excessive Somnolence</term>
<term>Dyskinesias</term>
<term>Parkinson Disease</term>
<term>Sleep Initiation and Maintenance Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Depressive Disorder</term>
</keywords>
<keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Depressive Disorder</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Demography</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Polysomnography</term>
<term>Questionnaires</term>
<term>Risk Factors</term>
<term>Severity of Illness Index</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Insomnie</term>
<term>Maladie de Parkinson</term>
<term>Pathologie du système nerveux</term>
<term>Sommeil</term>
<term>Trouble du sommeil</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Our objective is to evaluate nighttime sleep problems (NSP) and daytime sleepiness (DS) in patients with Parkinson's disease (PD) compared to controls, and to assess relations with demographic, disease‐related, and clinical characteristics in patients. NSP and DS were evaluated with the SCOPA‐SLEEP questionnaire in PD patients and controls. In patients, other disease‐related and clinical characteristics were also evaluated. Four hundred twenty PD patients [mean (SD) age 61.1 (11.5) years] and 150 controls [mean (SD) age 60.9 (9.9) years] participated in the study. Compared to controls, a significantly greater proportion of patients had excessive DS (EDS) (43 vs. 10%), excessive NSP (ENSP) (27 vs. 9%), or used sleep medication (17 vs. 12%). Difficulties with falling asleep were similar in both groups. In both patients and controls, women experienced more NSP than men. In patients, depressive symptoms accounted for 21% of NSP variance and was the major contributor to the total explained variance (30%). Furthermore, NSP were related to dopamine‐agonist and levodopa dose, whereas DS was related to age, dopamine‐agonist dose, and disease severity. NSP and DS occur frequently in PD, with EDS being reported more commonly than ENSP. No strong relations were found between DS and demographic or clinical variables. The strong relation between NSP and depressive symptoms in PD calls for future studies to explore the nature of this relation. © 2007 Movement Disorder Society</div>
</front>
</TEI>
<affiliations><list><country><li>Pays-Bas</li>
</country>
<region><li>Hollande-Méridionale</li>
</region>
<settlement><li>Leyde</li>
</settlement>
</list>
<tree><country name="Pays-Bas"><region name="Hollande-Méridionale"><name sortKey="Verbaan, Dagmar" sort="Verbaan, Dagmar" uniqKey="Verbaan D" first="Dagmar" last="Verbaan">Dagmar Verbaan</name>
</region>
<name sortKey="Marinus, Johan" sort="Marinus, Johan" uniqKey="Marinus J" first="Johan" last="Marinus">Johan Marinus</name>
<name sortKey="Van Hilten, Jacobus J" sort="Van Hilten, Jacobus J" uniqKey="Van Hilten J" first="Jacobus J." last="Van Hilten">Jacobus J. Van Hilten</name>
<name sortKey="Van Rooden, Stephanie M" sort="Van Rooden, Stephanie M" uniqKey="Van Rooden S" first="Stephanie M." last="Van Rooden">Stephanie M. Van Rooden</name>
<name sortKey="Visser, Martine" sort="Visser, Martine" uniqKey="Visser M" first="Martine" last="Visser">Martine Visser</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002733 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002733 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:BEE00B7711D7D7DF1865090033D443D02661DFA4 |texte= Nighttime sleep problems and daytime sleepiness in Parkinson's disease }}
This area was generated with Dilib version V0.6.23. |